Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
Go back to Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties| KKR & CO. L.P. (NYSE: KKR) | Delayed: 98.81 +0.62 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.19 | 52 Week High | $17.84 | |||
| Open | $97.51 | 52 Week Low | $10.89 | |||
| Day High | $99.24 | P/E | 42.96 | |||
| Day Low | $96.85 | EPS | $2.30 | |||
| Volume | 5,153,730 | |||||
| SmartPros Ltd. (NASDAQ: SPRO) | Delayed: 1.13 +0.01 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $3.85 | |||
| Open | $1.12 | 52 Week Low | $1.25 | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $-0.28 | |||
| Volume | 501,370 | |||||
